<DOC>
	<DOC>NCT00657527</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with 40mg of Rosuvastatin for 8 weeks will reduce the number of episodes of myocardial ischaemia suffered in subjects with coronary artery disease.</brief_summary>
	<brief_title>Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Evidence of Coronary arterial disease Suffering ischaemic episodes/exercise induced ischaemia Not taking any cholesterol lowering medication Unstable angina or heart attack less than one month before trial entry Coronary arterial surgery as defined by protocol Uncontrolled hypertension, diabetes, hypothyroidism or laboratory values as defined by the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Crestor</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Myocardial ischaemia.</keyword>
</DOC>